- Study finds Lilly's obesity drug Zepbound may lower hospital and ER costs for older adultsA real‑world analysis examined older patients with obesity or excess weight who were either treated with Eli Lilly’s drug Zepbound or not. The researchers tracked healthcare utilization over time t…
- Percutaneous Catheter Recall: Boston Scientific Removes ENROUTE Transcarotid Neuroprotection SystemENROUTE Transcarotid Neuroprotection Systems may have arterial sheath tip separation or partial tip separation during use.fda medwatch · 19h ago↗ source